# ACS Dobfar SPA – FDA Inspection, Nov 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/655df4a5-e416-415b-9b14-e4027dcc0160
Source feed: FDA_Inspections

> FDA inspection 1264901 of ACS Dobfar SPA, November 23, 2023. Classification: Voluntary Action Indicated (VAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264901
- Company Name: ACS Dobfar SPA
- Inspection Date: 2023-11-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1168950 - 2021-07-16
- [FDA Inspection 1061908 - 2018-07-20](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/4104288e-87e5-41b2-82f6-c61632dfc5e7)
- FDA Inspection 951618 - 2015-11-13
- FDA Inspection 856325 - 2013-07-04
- FDA Inspection 667137 - 2010-05-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/mra-munizn/11f33537-1745-4bda-859c-24ac35a3fe45)

Company: https://www.keypedia.com/companies/acs-dobfar-spa/fb834960-166f-40c6-86c1-4b06588d0304

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c